The Department of Veterans Affairs is soliciting quotes for a firm-fixed price Indefinite Quantity Indefinite Delivery (IDIQ) contract, under solicitation number 36C26224Q1704, for the supply of compounded chemotherapy medications. The contract will serve the VA Long Beach Healthcare System, requiring that vendors provide all specified medications from FDA-compliant facilities. This procurement is unrestricted and open to commercial suppliers, with a response deadline set for September 9, 2024.
Vendors must supply a comprehensive list of chemotherapy drugs, ensuring delivery meets rigorous safety and quality standards, including a minimum of 12 hours remaining on the Beyond-Use Date. The contractor’s pharmacy must hold valid licenses and adhere to strict packaging, labeling, and temperature monitoring requirements during transport. The agreement emphasizes the importance of prompt notification of product recalls or safety issues.
Vendors are advised to register on SAM.gov for eligibility, and communication regarding the RFP should be directed to the provided contact, Hestia Sim. The expected performance period spans from October 2024 through September 2029, inclusive of potential option years. The contract aligns with federal procurement regulations, reflecting the VA's commitment to patient care through accessing essential medications efficiently and securely.
The Department of Veterans Affairs seeks a vendor for a firm-fixed-price contract to supply and deliver compounded chemotherapy medications to the VA Long Beach Healthcare System. The contract, with a base year and four option years, aims to ensure a steady supply of these vital medications for patient care. Vendors must have a certified 503A pharmacy licensed to operate within California and comply with USP 797 standards. The comprehensive medication list includes brands and generics, such as Humira, Epogen, and Velcade, requiring precise handling and timely delivery. Responses to the solicitation are due by 10:00 AM on August 20, 2024. The government emphasizes the need for prompt delivery, with routine orders delivered by 6:00 AM PST the day of treatment and emergency orders same-day.
This government document is an amendment to a previous combined solicitation (Solicitation Number: 36C26224Q1704) regarding the procurement of compounded chemotherapy for the Department of Veterans Affairs (VA). The amendment addresses two key changes: it releases an updated solicitation document and extends the response deadline to September 9, 2024, at 10:00 AM Pacific Time. Offerors must acknowledge this amendment and resubmit their proposals based on the updates. The contract falls under Product Service Code 6505 and NAICS Code 325412, indicating its focus on pharmaceuticals. The execution of services will occur at the VA Long Beach Healthcare System's pharmacy in California. Additional contact information is provided for Hestia Sim, facilitating communication for interested parties. This amendment highlights the VA's ongoing commitment to updating procurement opportunities while ensuring compliance with established terms and conditions.
The document details a Request for Quotation (RFQ) from the VA for compounded chemotherapy services, identified by the primary ID 36C26224Q1704. It outlines specifications for billing rates, item descriptions, and relevant certifications required from vendors, including Environmental Attributes and Controlled Substance considerations. The RFQ is structured with various sections encompassing pricing information, packaging details, delivery instructions, and necessary compliance codes such as NAICS, UNSPSC, and SIC codes.
Key elements also include a contact for inquiries, specifics on order quantities, and the need for vendors to provide documentation verifying their adherence to federal standards. Emphasis is placed on potential environmental impacts through green product evaluations, while hazardous material management is outlined to ensure safe handling. The purpose of this RFQ is to procure vital pharmacy services within a specified timeframe while ensuring compliance with health and safety regulations. This initiative underscores the VA's commitment to providing safe and effective healthcare solutions through qualified vendors.